Skip to main content
Limin Group Co., Ltd. logo

Limin Group Co., Ltd. — Investor Relations & Filings

Ticker · 002734 ISIN · CNE100001WQ3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,833 across all filing types
Latest filing 2024-11-14 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 002734

About Limin Group Co., Ltd.

https://www.chinalimin.com

Limin Group Co., Ltd. specializes in the research, development, production, and sale of crop protection products, focusing primarily on fungicides, insecticides, and herbicides. The company maintains a diverse portfolio that includes active ingredients and formulations such as Mancozeb, Cymoxanil, Fosetyl-aluminum, and Glufosinate-ammonium. It operates large-scale manufacturing facilities and emphasizes technical innovation through dedicated research centers. Limin Group serves a global clientele, providing solutions aimed at improving agricultural productivity and food security. Its operations encompass the entire value chain from chemical synthesis to final product distribution, ensuring quality control and supply chain stability for international and domestic markets.

Recent filings

Filing Released Lang Actions
公司关于控股股东、实际控制人部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the partial release of pledged shares by the controlling shareholder and actual controller of the company. It details the number of shares released from pledge, the proportion of shares pledged, and other related information. There is no financial statement, audit information, or management discussion. The document is a regulatory announcement about share pledge status, which fits the category of Major Shareholding Notification (MRQ) as it involves significant shareholding changes related to pledge status. The document length is short and it is not a report or presentation but a formal announcement.
2024-11-14 Chinese
公司关于回购部分社会公众股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, prices, compliance with regulatory guidelines, and future intentions to continue the buyback. It does not contain financial statements or earnings data, nor is it an annual or quarterly report. It is not a regulatory filing or certification. The content clearly matches the description of a report on the company's transactions in its own shares (share repurchase). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is short and focused solely on the buyback progress, confirming it is not a full financial report but a specific transaction update.
2024-11-05 Chinese
公司关于与厦门昶科生物工程有限公司签署战略合作协议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the signing of a strategic cooperation agreement between the company and another entity. It details the nature of the agreement, the parties involved, and the potential impact on the company. There are no financial statements, regulatory certifications, voting results, or management changes reported. The document is relatively short (1956 characters) and serves as a disclosure of a business cooperation event rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is a typical corporate announcement about a strategic partnership, which aligns best with the category of Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2024-10-28 Chinese
公司2024年第四次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and procedures of the 2024 fourth extraordinary general meeting (临时股东大会) of Limin Holdings Group Co., Ltd. It details the legality of the meeting's convocation, attendance, voting procedures, and results. The document does not contain financial statements or performance data but focuses on the legal validation of the shareholder meeting and its resolutions. This type of document is not an annual report, earnings release, or management report but rather a legal opinion related to a shareholder meeting. It is not a simple announcement but a detailed legal opinion letter. Given the content and purpose, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA), as it includes official voting results and legal validation of the shareholder meeting outcomes.
2024-10-27 Chinese
公司第六届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the first meeting of the sixth board of directors of 利民控股集团股份有限公司. It includes election and appointment of the chairman, vice chairman, various board committees, president, senior management, securities affairs representative, and audit department head. It also mentions approval of the company's 2024 third quarter report but does not contain the report itself, only a reference to where it can be found. The document is focused on board and management changes and appointments, with detailed biographies of the appointed individuals. There is no financial data or earnings information presented, nor is it a full annual or quarterly report. The content aligns with announcements about changes in the company's board of directors and senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (7613 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2024-10-27 Chinese
公司关于 2024年前三季度计提信用减值损失及资产减值损失的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by a listed company regarding the provision for asset impairment losses and credit impairment losses for the first three quarters of 2024. It includes detailed accounting policies, amounts of impairment losses, and the board's statement on the reasonableness of the provisions. The document references compliance with Shenzhen Stock Exchange listing rules and accounting standards. It is not a full financial report like an interim or annual report, but a regulatory announcement about impairment provisions and their impact on the company. The document length is 4113 characters, which is relatively short and focused on a specific financial disclosure rather than comprehensive financial statements or management discussion. This fits best with a Regulatory Filing (RNS) as it is a regulatory announcement about impairment provisions and related disclosures, not a full report or earnings release.
2024-10-27 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.